Comparison of HPV genotypes and viral load between different sites of genital tract: The significance for cervical cancer screening

Cancer Epidemiology

Volumn 38, Issue 2, 2014, Pages 168-173

  Zhang, Shao Kai ^a   Ci, Pu Wa ^a   Velicer, Christine ^b   Kang, Le Ni ^a   Liu, Bin ^a   Cui, Jian Feng ^a   Chen, Feng ^a   Zhang, Xun ^a   Chang, Irene J ^c   Roberts, Christine C ^b   Smith, Jennifer S ^d   Chen, Wen ^a   Qiao, You Lin ^a  

^a CANCER HOSPITAL   (China)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d University of North Carolina at Chapel Hill   (United States)

Author keywords

Genital tract; Genotype; Human papillomavirus; Intraepithelial neoplasia; Viral load

Indexed keywords

ARTICLE; CANCER SCREENING; COMPARATIVE STUDY; FEMALE; FEMALE GENITAL SYSTEM; GENETIC VARIABILITY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CANCER; VAGINA SMEAR; VIRUS INFECTION; VIRUS LOAD; WART VIRUS; ADOLESCENT; ADULT; CLASSIFICATION; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; GENITALIA, FEMALE; GENOTYPE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84898022395     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.01.004     Document Type: Article

References (27)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
2. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000, 92:690-698.
3. De Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., Zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
4. Trottier H., Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(Suppl. 1):S1-S15.
5. Trottier H., Burchell A.N. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics 2009, 12:291-307.
6. Gage J.C., Ajenifuja K.O., Wentzensen N.A., Adepiti A.C., Eklund C., Reilly M., et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Int J Cancer 2012, 130:2111-2117.
7. Chen H.C., You S.L., Hsieh C.Y., Schiffman M., Lin C.Y., Pan M.H., et al. Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women. Int J Cancer 2011, 128:1192-1203.
8. Kjaer S.K., Breugelmans G., Munk C., Junge J., Watson M., Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008, 123:1864-1870.
9. Gravitt P.E., Kovacic M.B., Herrero R., Schiffman M., Bratti C., Hildesheim A., et al. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 2007, 121:2787-2793.
10. Flores R., Papenfuss M., Klimecki W.T., Giuliano A.R. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 2006, 118:1187-1193.
11. Tsai H.T., Wu C.H., Lai H.L., Li R.N., Tung Y.C., Chuang H.Y., et al. Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk. Cancer Epidemiol Biomarkers Prev 2005, 14:2544-2549.
12. Guan P., Howell-Jones R., Li N., Bruni L., De Sanjosé S., Franceschi S., et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012, 131:2349-2359.
13. Barzon L., Militello V., Pagni S., Franchin E., Dal Bello F., Mengoli C., et al. Distribution of human papillomavirus types in the anogenital tract of females and males. J Med Virol 2010, 82:1424-1430.
14. Gonçalves M.A., Randi G., Arslan A., Villa L.L., Burattini M.N., Franceschi S., et al. HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect Agent Cancer 2008, 3:5.
15. Taylor S., Wang C., Wright T.C., Denny L., Kuhn L. A comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treat. Int J Cancer 2011, 129(4):879-886.
16. Belinson J.L., Hu S., Niyazi M., Pretorius R.G., Wang H., Wen C., et al. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection. Int J Cancer 2010, 127:1151-1157.
17. Castle P.E., Solomon D., Wheeler C.M., Gravitt P.E., Wacholder S., Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 2008, 46:2595-2604.
18. Castle P.E., Schiffman M., Burk R.D., Wacholder S., Hildesheim A., Herrero R., et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2002, 11:1394-1399.
19. Belinson J., Qiao Y.L., Pretorius R., Zhang W.H., Elson P., Li L., et al. Shanxi province cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001, 83:439-444.
20. Pretorius R.G., Bao Y.P., Belinson J.L., Burchette R.J., Smith J.S., Qiao Y.L. Inappropriate gold standard bias in cervical cancer screening studies. Int J Cancer 2007, 121:2218-2224.
21. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
22. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., Koutsky L.A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-226.
23. Tábora N., Ferrera A., Bakkers J.M., Massuger L.F., Melchers W.J. High HPV 16 viral load is associated with increased cervical dysplasia in Honduran women. Am J Trop Med Hyg 2008, 78:843-846.
24. Lee H.P., Kim S.O., Hwang T.S., Bae J.M., Kim S.N., Kim J.W., et al. Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses. J Med Virol 2011, 83(3):471-482.
25. Szarewski A., Cadman L., Mallett S., Austin J., Londesborough P., Waller J., et al. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007, 14:34-42.
26. Bhatla N., Dar L., Patro A.R., Kumar P., Kriplani A., Gulati A., et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?. Cancer Epidemiol 2009, 33:446-450.
27. Belinson J.L., Du H., Yang B., Wu R., Belinson S.E., Qu X., et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer 2012, 130:1855-1860.